Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

Researchers are developing a new tool for liquid biopsy that can detect RNA biomarkers from cancer cells in a patient’s blood much more accurately and completely than other existing methods. This could soon provide doctors with a more complete picture of an individual’s disease, improving their chances of finding the best treatment, while also sparing patients the pain, inconvenience and long wait times associated with surgical biopsies.